Multicenter Prospective Trial on Hemorrhoids
Launched by STONY BROOK UNIVERSITY · Aug 7, 2017
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
This is a multicenter, parallel arm, non-randomized prospective data collection trial comparing Ferguson hemorrhoidectomy and THD in terms of recurrence rates at one-year. All subjects will already be scheduled for either Ferguson or THD hemorrhoidectomy, the surgery is NOT part of the research. Although a randomized study would control for variation among surgeons, this study design provides the best patient safety since the surgeons will perform the technique they do most frequently. Variability in the patient population will be managed with a conservative sample size, which allows for a ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patient must be:
- • At least 18 years-old
- • Able to sign informed consent
- • Presenting with prolapsed, non-incarcerated, reducible hemorrhoids in at least 3 columns at physical examination and scheduled for either Ferguson or THD hemorrhoidectomy.
- Exclusion Criteria:
- • Any prior anorectal surgery except for conventional office-based interventions (rubber band ligation, sclerotherapy, and infrared coagulation)
- • Prior pelvic radiotherapy
- • Inflammatory bowel diseases
- • Pre-existing fecal incontinence (Wexner score5 ≥8)
- • Pre-existing chronic anal diseases
- • Grades III and IV gynecological and obstetrical trauma per medical history and/or physical examination
- • Connective tissue disorders
- • Subject is pregnant
- • Subject is under incarceration
About Stony Brook University
Stony Brook University, a prominent research institution located in New York, is dedicated to advancing medical science through innovative clinical trials and research initiatives. As a sponsor, Stony Brook University leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient care and health outcomes. With a commitment to ethical standards and collaborative partnerships, the university fosters an environment conducive to groundbreaking discoveries and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stony Brook, New York, United States
Patients applied
Trial Officials
George Angelos, MD
Principal Investigator
Stony Brook University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials